Your browser doesn't support javascript.
loading
Financial burdens of HIV and chronic disease on people living with HIV in Côte d'Ivoire: A cross-sectional out-of-pocket expenditure study.
Stelmach, Rachel D; Rabkin, Miriam; Abo, Kouame; Ahoba, Irma; Gildas Anago, Mahena; Boccanera, Rodrigo; Brou, Hermann; Flueckiger, Rebecca; Hartsough, Kieran; Msukwa, Martin; Zech, Jennifer; Young, Felicity; Nugent, Rachel.
Afiliação
  • Stelmach RD; RTI International, Washington, DC, United States of America.
  • Rabkin M; ICAP at Columbia University, New York, NY, United States of America.
  • Abo K; Programme National de Lutte Contre le SIDA (PNLS), Abidjan, Côte d'Ivoire.
  • Ahoba I; Programme National de Lutte Contre le SIDA (PNLS), Abidjan, Côte d'Ivoire.
  • Gildas Anago M; ICAP at Columbia University, New York, NY, United States of America.
  • Boccanera R; Health Resources and Services Administration, Rockville, MD, United States of America.
  • Brou H; ICAP at Columbia University, New York, NY, United States of America.
  • Flueckiger R; RTI International, Atlanta, GA, United States of America.
  • Hartsough K; ICAP at Columbia University, New York, NY, United States of America.
  • Msukwa M; ICAP at Columbia University, New York, NY, United States of America.
  • Zech J; ICAP at Columbia University, New York, NY, United States of America.
  • Young F; RTI International, Brisbane, Australia.
  • Nugent R; RTI International, Seattle, WA, United States of America.
PLoS One ; 16(7): e0255074, 2021.
Article em En | MEDLINE | ID: mdl-34324545
ABSTRACT

BACKGROUND:

Although people living with HIV in Côte d'Ivoire receive antiretroviral therapy (ART) at no cost, other out-of-pocket (OOP) spending related to health can still create a barrier to care.

METHODS:

A convenience sample of 400 adults living with HIV for at least 1 year in Côte d'Ivoire completed a survey on their health spending for HIV and chronic non-communicable diseases (NCDs). In addition to descriptive statistics, we performed simple linear regression analyses with bootstrapped 95% confidence intervals.

FINDINGS:

365 participants (91%) reported OOP spending for HIV care, with a median of $16/year (IQR 5-48). 34% of participants reported direct costs with a median of $2/year (IQR 1-41). No participants reported user fees for HIV services. 87% of participants reported indirect costs, with a median of $17/year (IQR 7-41). 102 participants (26%) reported at least 1 NCD. Of these, 80 (78%) reported OOP spending for NCD care, with a median of $50/year (IQR 6-107). 76 participants (95%) with both HIV and NCDs reported direct costs, and 48% reported paying user fees for NCD services. Participants had missed a median of 2 HIV appointments in the past year (IQR 2-3). Higher OOP costs were not associated with the number of HIV appointments missed. 21% of participants reported spending over 10% of household income on HIV and/or NCD care. DISCUSSION AND

CONCLUSIONS:

Despite the availability of free ART, most participants reported OOP spending. OOP costs were much higher for participants with co-morbid NCDs.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Gastos em Saúde Tipo de estudo: Health_economic_evaluation / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adult / Humans / Male / Middle aged País como assunto: Africa Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Gastos em Saúde Tipo de estudo: Health_economic_evaluation / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adult / Humans / Male / Middle aged País como assunto: Africa Idioma: En Ano de publicação: 2021 Tipo de documento: Article